Literature DB >> 12812718

Detection of mutations in quinolone resistance-determining regions in levofloxacin- and methicillin-resistant Staphylococcus aureus: effects of the mutations on fluoroquinolone MICs.

Toshinobu Horii1, Yasuhiro Suzuki, Akio Monji, Motoki Morita, Hideaki Muramatsu, Yoko Kondo, Matsuko Doi, Akihiro Takeshita, Takashi Kanno, Masato Maekawa.   

Abstract

The minimum inhibitory concentrations (MICs) of 18 antibiotics were determined for 66 clinical isolates of staphylococci. Genotypes, mutations in the quinolone resistance-determining regions (QRDRs), and effect of efflux were determined in the 18 levofloxacin-resistant isolates, for which the MICs of levofloxacin were high (> or =8 microg/ml). The increased levofloxacin resistance mainly resulted from some combinations of mutations in the QRDRs, although NorA-mediated efflux may play a minor role in resistance. A combination of mutations in GrlA (Ser80Phe), GrlB (Pro451Ser), and GyrA (Ser84Leu) was found in 4 methicillin-resistant Staphylococcus aureus (MRSA) isolates that were unrelated genotypically. The mutations in grlA QRDR varied in the isolates classified as being in an identical pulsed-field gel electrophoresis (PFGE) group, although the grlB, gyrA, and gyrB QRDRs were the same. These results suggest that the patterns of amino acid mutations in the QRDRs can provide distinct epidemiologic information from PFGE genotypes in fluoroquinolone-resistant MRSA. A combination of at least three mutations in GrlA, GrlB, and/or GyrA is required to increase the MICs of fluoroquinolones, although all of the levofloxacin-resistant MRSA retained the MICs of sitafloxacin in the range of 1 to 2 microg/ml.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12812718     DOI: 10.1016/s0732-8893(03)00037-3

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  17 in total

1.  Antistaphylococcal activity of DX-619 alone and in combination with vancomycin, teicoplanin, and linezolid assessed by time-kill synergy testing.

Authors:  Kim Credito; Genrong Lin; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2007-01-29       Impact factor: 5.191

2.  Use of a three-dimensional microarray system for detection of levofloxacin resistance and the mec A gene in Staphylococcus aureus.

Authors:  Tomonori Nagaoka; Toshinobu Horii; Takatomo Satoh; Tomoko Ito; Akio Monji; Akihiro Takeshita; Masato Maekawa
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.

Authors:  Tatiana Bogdanovich; Duygu Esel; Linda M Kelly; Bülent Bozdogan; Kim Credito; Gengrong Lin; Kathy Smith; Lois M Ednie; Dianne B Hoellman; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

4.  Studies on the antimicrobial properties of N-acylated ciprofloxacins.

Authors:  Ryan Cormier; Whittney N Burda; Lacey Harrington; Jordan Edlinger; Karthik M Kodigepalli; John Thomas; Rebecca Kapolka; Glen Roma; Burt E Anderson; Edward Turos; Lindsey N Shaw
Journal:  Bioorg Med Chem Lett       Date:  2012-07-01       Impact factor: 2.823

5.  Novel Ser79Leu and Ser81Ile substitutions in the quinolone resistance-determining regions of ParC topoisomerase IV and GyrA DNA gyrase subunits from recent fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates.

Authors:  Nataliya Korzheva; Todd A Davies; Raul Goldschmidt
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

6.  Bactericidal activity of besifloxacin against staphylococci, Streptococcus pneumoniae and Haemophilus influenzae.

Authors:  Wolfgang Haas; Chris M Pillar; Christine K Hesje; Christine M Sanfilippo; Timothy W Morris
Journal:  J Antimicrob Chemother       Date:  2010-04-30       Impact factor: 5.790

7.  Antimicrobial activity of DC-159a, a new fluoroquinolone, against 1,149 recently collected clinical isolates.

Authors:  Ronald N Jones; Thomas R Fritsche; Helio S Sader
Journal:  Antimicrob Agents Chemother       Date:  2008-06-23       Impact factor: 5.191

8.  Characterization of new staphylococcal cassette chromosome mec (SCCmec) and topoisomerase genes in fluoroquinolone- and methicillin-resistant Staphylococcus pseudintermedius.

Authors:  Sybill Descloux; Alexandra Rossano; Vincent Perreten
Journal:  J Clin Microbiol       Date:  2008-02-27       Impact factor: 5.948

9.  Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.

Authors:  Jijun Cheng; Jane A Thanassi; Christy L Thoma; Barton J Bradbury; Milind Deshpande; Michael J Pucci
Journal:  Antimicrob Agents Chemother       Date:  2007-05-14       Impact factor: 5.191

10.  Mutations in the quinolone resistance determining region in Staphylococcus epidermidis recovered from conjunctiva and their association with susceptibility to various fluoroquinolones.

Authors:  M Yamada; J Yoshida; S Hatou; T Yoshida; Y Minagawa
Journal:  Br J Ophthalmol       Date:  2008-05-06       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.